{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:18:53Z","timestamp":1784593133317,"version":"3.55.0"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,10,12]],"date-time":"2015-10-12T00:00:00Z","timestamp":1444608000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1007\/s10620-015-3925-0","type":"journal-article","created":{"date-parts":[[2015,10,13]],"date-time":"2015-10-13T02:23:22Z","timestamp":1444703002000},"page":"673-683","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Pathophysiology and Therapeutic Strategies for Symptomatic Uncomplicated Diverticular Disease of the Colon"],"prefix":"10.1007","volume":"61","author":[{"given":"Eleonora","family":"Scaioli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Colecchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Marasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramona","family":"Schiumerini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Festi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,10,12]]},"reference":[{"key":"3925_CR1","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1463-1318.2009.02121.x","volume":"13","author":"SS Fong","year":"2011","unstructured":"Fong SS, Tan EY, Foo A, Sim R, Cheong DMO. The changing trend of diverticular disease in a developing nation. Colorectal Dis. 2011;13:312\u2013316.","journal-title":"Colorectal Dis"},{"key":"3925_CR2","doi-asserted-by":"crossref","first-page":"219","DOI":"10.4103\/1117-1936.169543","volume":"19","author":"OI Alatise","year":"2012","unstructured":"Alatise OI, Arigbabu AO, Agbakwuru EA, Lawal OO, Ndububa DA, Ojo OS. Spectrum of colonoscopy findings in Ile-Ife Nigeria. Niger Postgrad Med J. 2012;19:219\u2013224.","journal-title":"Niger Postgrad Med J"},{"key":"3925_CR3","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0140-6736(04)15597-9","volume":"363","author":"N Stollman","year":"2004","unstructured":"Stollman N, Raskin JB. Diverticular disease of the colon. Lancet. 2004;363:631\u2013639.","journal-title":"Lancet"},{"key":"3925_CR4","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1177\/1756283X11412820","volume":"4","author":"F Sope\u00f1a","year":"2011","unstructured":"Sope\u00f1a F, Lanas A. Management of colonic diverticular disease with poorly absorbed antibiotics and other therapies. Therap Adv Gastroenterol. 2011;4:365\u2013374.","journal-title":"Therap Adv Gastroenterol"},{"key":"3925_CR5","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1177\/2050640614547068","volume":"2","author":"R Cuomo","year":"2014","unstructured":"Cuomo R, Barbara G, Pace F, et al. Italian consensus conference for colonic diverticulosis and diverticular disease. United Eur Gastroenterol J. 2014;2:413\u2013442.","journal-title":"United Eur Gastroenterol J"},{"key":"3925_CR6","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1097\/01.mcg.0000124003.07433.ee","volume":"38","author":"MH Floch","year":"2004","unstructured":"Floch MH, Bina I. The natural history of diverticulitis: fact and theory. J Clin Gastroenterol. 2004;38:S2\u2013S7.","journal-title":"J Clin Gastroenterol"},{"key":"3925_CR7","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/ajcn\/60.5.757","volume":"60","author":"WH Aldoori","year":"1994","unstructured":"Aldoori WH, Giovannucci EL, Rimm EB, Wing AL, Trichopoulos DV, Willett WC. A prospective study of diet and the risk of symptomatic diverticular disease in men. Am J Clin Nutr. 1994;60:757\u2013764.","journal-title":"Am J Clin Nutr"},{"key":"3925_CR8","doi-asserted-by":"crossref","first-page":"G1060","DOI":"10.1152\/ajpgi.00202.2007","volume":"294","author":"A Seth","year":"2008","unstructured":"Seth A, Yan F, Polk DB, Rao RK. Probiotics ameliorate the hydrogen peroxide-induced epithelial barrier disruption by a PKC- and MAP kinase-dependent mechanism. Am J Physiol Gastrointest Liver Physiol. 2008;294:G1060\u2013G1069.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"3925_CR9","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1097\/01.mcg.0000225502.29498.ba","volume":"40","author":"MH Floch","year":"2006","unstructured":"Floch MH. A hypothesis: Is diverticulitis a type of inflammatory bowel disease? J Clin Gastroenterol. 2006;40:S121\u2013S125.","journal-title":"J Clin Gastroenterol"},{"key":"3925_CR10","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1517\/14656566.2014.903922","volume":"15","author":"A Tursi","year":"2014","unstructured":"Tursi A. New physiopathological and therapeutic approaches to diverticular disease: an update. Expert Opin Pharmacother. 2014;15:1005\u20131017.","journal-title":"Expert Opin Pharmacother"},{"key":"3925_CR11","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00384-012-1554-z","volume":"28","author":"G Bassotti","year":"2013","unstructured":"Bassotti G, Villanacci V, Nascimbeni R, et al. The role of colonic mast cells and myenteric plexitis in patients with diverticular disease. Int J Colorectal Dis. 2013;28:267\u2013272.","journal-title":"Int J Colorectal Dis"},{"key":"3925_CR12","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/MCG.0b013e3180653ca2","volume":"42","author":"A Tursi","year":"2008","unstructured":"Tursi A, Brandimarte G, Elisei W, et al. Assessment and grading of mucosal inflammation in colonic diverticular disease. J Clin Gastroenterol. 2008;42:699\u2013703.","journal-title":"J Clin Gastroenterol"},{"key":"3925_CR13","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1080\/00365520802321204","volume":"44","author":"R Cianci","year":"2009","unstructured":"Cianci R, Iacopini F, Petruzziello L, Cammarota G, Pandolfi F, Costamagna G. Involvement of central immunity in uncomplicated diverticular disease. Scand J Gastroenterol. 2009;44:108\u2013115.","journal-title":"Scand J Gastroenterol"},{"key":"3925_CR14","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1097\/MCG.0b013e3181dad979","volume":"44","author":"A Tursi","year":"2010","unstructured":"Tursi A, Elisei W, Brandimarte G, Giorgetti GM, Aiello F. Predictive value of serologic markers of degree of histologic damage in acute uncomplicated colonic diverticulitis. J Clin Gastroenterol. 2010;44:702\u2013706.","journal-title":"J Clin Gastroenterol"},{"key":"3925_CR15","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/BF02234790","volume":"44","author":"AF Horgan","year":"2001","unstructured":"Horgan AF, McConnell EJ, Wolff BG, The S, Paterson C. Atypical diverticular disease: surgical results. Dis Colon Rectum. 2001;44:1315\u20131318.","journal-title":"Dis Colon Rectum"},{"key":"3925_CR16","doi-asserted-by":"crossref","first-page":"847-e58","DOI":"10.1111\/j.1365-2982.2009.01308.x","volume":"21","author":"J Simpson","year":"2009","unstructured":"Simpson J, Sundler F, Humes DJ, Jenkins D, Scholefield JH, Spiller RC. Post inflammatory damage to the enteric nervous system in diverticular disease and its relationship to symptoms. Neurogastroenterol Motil. 2009;21:847-e58.","journal-title":"Neurogastroenterol Motil"},{"key":"3925_CR17","doi-asserted-by":"crossref","first-page":"e258","DOI":"10.1111\/j.1463-1318.2012.02926.x","volume":"14","author":"A Tursi","year":"2012","unstructured":"Tursi A, Elisei W, Brandimarte G, et al. Musosal tumour necrosis factor \u03b1 in diverticular disease of the colon is overexpressed with disease severity. Colorectal Dis. 2012;14:e258\u2013e263.","journal-title":"Colorectal Dis"},{"key":"3925_CR18","doi-asserted-by":"crossref","first-page":"318-e163","DOI":"10.1111\/j.1365-2982.2011.01863.x","volume":"24","author":"DJ Humes","year":"2012","unstructured":"Humes DJ, Simpson J, Smith J, et al. Visceral hypersensitivity in symptomatic diverticular disease and the role of neuropeptides and low grade inflammation. Neurogastroenterol Motil. 2012;24:318-e163.","journal-title":"Neurogastroenterol Motil"},{"key":"3925_CR19","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1159\/000335721","volume":"30","author":"R Spiller","year":"2012","unstructured":"Spiller R. Is it diverticular disease or is it irritable bowel syndrome? Dig Dis. 2012;30:64\u201369.","journal-title":"Dig Dis"},{"key":"3925_CR20","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1038\/ajg.2014.367","volume":"109","author":"R Spiller","year":"2014","unstructured":"Spiller R. Editorial: new thoughts on the association between diverticulosis and irritable bowel syndrome. Am J Gastroenterol. 2014;109:1906\u20131908.","journal-title":"Am J Gastroenterol"},{"key":"3925_CR21","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1111\/eci.12152","volume":"43","author":"R Cuomo","year":"2013","unstructured":"Cuomo R, Barbara G, Andreozzi P, et al. Symptom patterns can distinguish diverticular disease from irritable bowel syndrome. Eur J Clin Invest. 2013;43:1147\u20131155.","journal-title":"Eur J Clin Invest"},{"key":"3925_CR22","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s11894-011-0195-7","volume":"13","author":"G Barbara","year":"2011","unstructured":"Barbara G, Cremon C, De Giorgio R, et al. Mechanisms underlying visceral hypersensitivity in irritable bowel syndrome. Curr Gastroenterol Rep. 2011;13:308\u2013315.","journal-title":"Curr Gastroenterol Rep"},{"key":"3925_CR23","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/0016-5085(95)90267-8","volume":"109","author":"H Mertz","year":"1995","unstructured":"Mertz H, Naliboff B, Munakata J, Niazi N, Mayer EA. Altered rectal perception is a biological marker of patients with irritable bowel syndrome. Gastroenterology. 1995;109:40\u201352.","journal-title":"Gastroenterology"},{"key":"3925_CR24","doi-asserted-by":"crossref","first-page":"S-811","DOI":"10.1016\/S0016-5085(12)63157-6","volume":"142","author":"ER Cohen","year":"2012","unstructured":"Cohen ER, Fuller G, Bolus R, et al. Tu1363 evidence for post-diverticulitis irritable bowel syndrome (Pdv-IBS): longitudinal analysis reveals higher incidence of IBS in DV cases vs. controls. Gastroenterology. 2012;142:S-811\u2013S-812.","journal-title":"Gastroenterology"},{"key":"3925_CR25","doi-asserted-by":"crossref","first-page":"iv63","DOI":"10.1136\/gut.47.suppl_4.iv63","volume":"47","author":"L Bueno","year":"2000","unstructured":"Bueno L. Neuroimmune alterations of ENS functioning. Gut. 2000;47:iv63\u2013iv65. discussion iv76.","journal-title":"Gut"},{"key":"3925_CR26","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/S0016-5085(96)70034-3","volume":"111","author":"SM Collins","year":"1996","unstructured":"Collins SM. The immunomodulation of enteric neuromuscular function: implications for motility and inflammatory disorders. Gastroenterology. 1996;111:1683\u20131699.","journal-title":"Gastroenterology"},{"key":"3925_CR27","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0016-5085(94)90086-8","volume":"107","author":"EA Mayer","year":"1994","unstructured":"Mayer EA, Gebhart GF. Basic and clinical aspects of visceral hyperalgesia. Gastroenterology. 1994;107:271\u2013293.","journal-title":"Gastroenterology"},{"key":"3925_CR28","doi-asserted-by":"crossref","first-page":"G834","DOI":"10.1152\/ajpgi.2000.278.6.G834","volume":"278","author":"GF Gebhart","year":"2000","unstructured":"Gebhart GF. Pathobiology of visceral pain: molecular mechanisms and therapeutic implications IV: visceral afferent contributions to the pathobiology of visceral pain. Am J Physiol Gastrointest Liver Physiol. 2000;278:G834\u2013G838.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"3925_CR29","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/0016-5085(95)90378-X","volume":"109","author":"K Jacobson","year":"1995","unstructured":"Jacobson K, McHugh K, Collins SM. Experimental colitis alters myenteric nerve function at inflamed and noninflamed sites in the rat. Gastroenterology. 1995;109:718\u2013722.","journal-title":"Gastroenterology"},{"key":"3925_CR30","first-page":"314","volume":"122","author":"J Simpson","year":"2002","unstructured":"Simpson J, Haji-Suyoi A, Jenkins D, Scholefield JH, Stach W. Quantification of neurological changes in resection specimens with complicated and uncomplicated diverticular disease. Gastroenterology. 2002;122:314.","journal-title":"Gastroenterology"},{"key":"3925_CR31","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1053\/gast.1997.v113.pm9322517","volume":"113","author":"G Barbara","year":"1997","unstructured":"Barbara G, Vallance BA, Collins SM. Persistent intestinal neuromuscular dysfunction after acute nematode infection in mice. Gastroenterology. 1997;113:1224\u20131232.","journal-title":"Gastroenterology"},{"key":"3925_CR32","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.gtc.2005.02.007","volume":"34","author":"P Bercik","year":"2005","unstructured":"Bercik P, Verdu EF, Collins SM. Is irritable bowel syndrome a low-grade inflammatory bowel disease? Gastroenterol Clin North Am. 2005;34:235\u2013245. vi\u2013vii.","journal-title":"Gastroenterol Clin North Am"},{"key":"3925_CR33","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1136\/gut.2003.018093","volume":"53","author":"CHM Clemens","year":"2004","unstructured":"Clemens CHM, Samsom M, Roelofs J, van Berge Henegouwen GP, Smout AJPM. Colorectal visceral perception in diverticular disease. Gut. 2004;53:717\u2013722.","journal-title":"Gut"},{"key":"3925_CR34","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/DCR.0000000000000078","volume":"57","author":"L Daniels","year":"2014","unstructured":"Daniels L, Philipszoon LE, Boermeester MA. A hypothesis: important role for gut microbiota in the etiopathogenesis of diverticular disease. Dis Colon Rectum. 2014;57:539\u2013543.","journal-title":"Dis Colon Rectum"},{"key":"3925_CR35","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1038\/ajg.2012.194","volume":"107","author":"LL Strate","year":"2012","unstructured":"Strate LL, Modi R, Cohen E, Spiegel BMR. Diverticular disease as a chronic illness: evolving epidemiologic and clinical insights. Am J Gastroenterol. 2012;107:1486\u20131493.","journal-title":"Am J Gastroenterol"},{"key":"3925_CR36","doi-asserted-by":"crossref","first-page":"38105","DOI":"10.1074\/jbc.R300028200","volume":"278","author":"S Akira","year":"2003","unstructured":"Akira S. Toll-like receptor signaling. J Biol Chem. 2003;278:38105\u201338108.","journal-title":"J Biol Chem"},{"key":"3925_CR37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/696812","volume":"2014","author":"R Cianci","year":"2014","unstructured":"Cianci R, Frosali S, Pagliari D, et al. Uncomplicated diverticular disease: innate and adaptive immunity in human gut mucosa before and after rifaximin. J Immunol Res. 2014;2014:1\u201311.","journal-title":"J Immunol Res"},{"key":"3925_CR38","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1111\/j.1365-2036.2011.04606.x","volume":"33","author":"M Bianchi","year":"2011","unstructured":"Bianchi M, Festa V, Moretti A, et al. Meta-analysis: long-term therapy with rifaximin in the management of uncomplicated diverticular disease. Aliment Pharmacol Ther. 2011;33:902\u2013910.","journal-title":"Aliment Pharmacol Ther"},{"key":"3925_CR39","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1017\/S0022172400069035","volume":"86","author":"AM Tomkins","year":"1981","unstructured":"Tomkins AM, Bradley AK, Oswald S, Drasar BS. Diet and the faecal microflora of infants, children and adults in rural Nigeria and urban UK. J Hyg. 1981;86:285\u2013293.","journal-title":"J Hyg"},{"key":"3925_CR40","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.3945\/jn.112.158766","volume":"142","author":"S Hooda","year":"2012","unstructured":"Hooda S, Boler BMV, Serao MCR, et al. 454 pyrosequencing reveals a shift in fecal microbiota of healthy adult men consuming polydextrose or soluble corn fiber. J Nutr. 2012;142:1259\u20131265.","journal-title":"J Nutr"},{"key":"3925_CR41","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1007\/s10096-014-2162-3","volume":"33","author":"L Daniels","year":"2014","unstructured":"Daniels L, Budding AE, de Korte N, et al. Fecal microbiome analysis as a diagnostic test for diverticulitis. Eur J Clin Microbiol Infect Dis. 2014;33:1927\u20131936.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"3925_CR42","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S1542-3565(04)00614-7","volume":"3","author":"G Bassotti","year":"2005","unstructured":"Bassotti G, Battaglia E, De Roberto G, Morelli A, Tonini M, Villanacci V. Alterations in colonic motility and relationship to pain in colonic diverticulosis. Clin Gastroenterol Hepatol. 2005;3:248\u2013253.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"3925_CR43","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1136\/jcp.2005.026112","volume":"58","author":"G Bassotti","year":"2005","unstructured":"Bassotti G, Battaglia E, Bellone G, et al. Interstitial cells of Cajal, enteric nerves, and glial cells in colonic diverticular disease. J Clin Pathol. 2005;58:973\u2013977.","journal-title":"J Clin Pathol"},{"key":"3925_CR44","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1365-201X.2000.00769.x","volume":"170","author":"M Hanani","year":"2000","unstructured":"Hanani M, Freund HR. Interstitial cells of Cajal\u2014their role in pacing and signal transmission in the digestive system. Acta Physiol Scand. 2000;170:177\u2013190.","journal-title":"Acta Physiol Scand"},{"key":"3925_CR45","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/0016-5085(90)90953-X","volume":"99","author":"P Milner","year":"1990","unstructured":"Milner P, Crowe R, Kamm MA, Lennard-Jones JE, Burnstock G. Vasoactive intestinal polypeptide levels in sigmoid colon in idiopathic constipation and diverticular disease. Gastroenterology. 1990;99:666\u2013675.","journal-title":"Gastroenterology"},{"key":"3925_CR46","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00384-011-1308-3","volume":"27","author":"C \u00dcnl\u00fc","year":"2012","unstructured":"\u00dcnl\u00fc C, Daniels L, Vrouenraets BC, Boermeester MA. A systematic review of high-fibre dietary therapy in diverticular disease. Int J Colorectal Dis. 2012;27:419\u2013427.","journal-title":"Int J Colorectal Dis"},{"key":"3925_CR47","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S0140-6736(77)92112-2","volume":"1","author":"AJ Brodribb","year":"1977","unstructured":"Brodribb AJ. Treatment of symptomatic diverticular disease with a high-fibre diet. Lancet. 1977;1:664\u2013666.","journal-title":"Lancet"},{"key":"3925_CR48","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1136\/bmj.282.6276.1629-d","volume":"282","author":"MH Ornstein","year":"1981","unstructured":"Ornstein MH, Littlewood ER, Baird IM, Fowler J, Cox AG. Are fibre supplements really necessary in diverticular disease of the colon? Br Med J (Clin Res Ed). 1981;282:1629\u20131630.","journal-title":"Br Med J (Clin Res Ed)"},{"key":"3925_CR49","first-page":"157","volume":"67","author":"WJ Hodgson","year":"1977","unstructured":"Hodgson WJ. The placebo effect. Is it important in diverticular disease? Am J Gastroenterol. 1977;67:157\u2013162.","journal-title":"Am J Gastroenterol"},{"key":"3925_CR50","first-page":"173","volume":"67","author":"AL Leahy","year":"1985","unstructured":"Leahy AL, Ellis RM, Quill DS, Peel AL. High fibre diet in symptomatic diverticular disease of the colon. Ann R Coll Surg Engl. 1985;67:173\u2013174.","journal-title":"Ann R Coll Surg Engl"},{"key":"3925_CR51","doi-asserted-by":"crossref","first-page":"d4131","DOI":"10.1136\/bmj.d4131","volume":"343","author":"FL Crowe","year":"2011","unstructured":"Crowe FL, Appleby PN, Allen NE, Key TJ. Diet and risk of diverticular disease in Oxford cohort of European Prospective Investigation into Cancer and Nutrition (EPIC): prospective study of British vegetarians and non-vegetarians. BMJ. 2011;343:d4131.","journal-title":"BMJ"},{"key":"3925_CR52","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1093\/jn\/128.4.714","volume":"128","author":"WH Aldoori","year":"1998","unstructured":"Aldoori WH, Giovannucci EL, Rockett HR, Sampson L, Rimm EB, Willett WC. A prospective study of dietary fiber types and symptomatic diverticular disease in men. J Nutr. 1998;128:714\u2013719.","journal-title":"J Nutr"},{"key":"3925_CR53","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1001\/jama.300.8.907","volume":"300","author":"LL Strate","year":"2008","unstructured":"Strate LL, Liu YL, Syngal S, Aldoori WH, Giovannucci EL. Nut, corn, and popcorn consumption and the incidence of diverticular disease. JAMA. 2008;300:907\u2013914.","journal-title":"JAMA"},{"key":"3925_CR54","first-page":"C4453","volume":"59","author":"JC Andersen","year":"2012","unstructured":"Andersen JC, Bundgaard L, Elbr\u00f8nd H, Laurberg S, Walker LR, St\u00f8vring J. Danish national guidelines for treatment of diverticular disease. Dan Med J. 2012;59:C4453.","journal-title":"Dan Med J"},{"key":"3925_CR55","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s004649901007","volume":"13","author":"L K\u00f6hler","year":"1999","unstructured":"K\u00f6hler L, Sauerland S, Neugebauer E. Diagnosis and treatment of diverticular disease: results of a consensus development conference. The Scientific Committee of the European Association for Endoscopic Surgery. Surg Endosc. 1999;13:430\u2013436.","journal-title":"Surg Endosc"},{"key":"3925_CR56","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1111\/j.1572-0241.1999.01501.x","volume":"94","author":"NH Stollman","year":"1999","unstructured":"Stollman NH, Raskin JB. Diagnosis and management of diverticular disease of the colon in adults. Ad Hoc Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol. 1999;94:3110\u20133121.","journal-title":"Am J Gastroenterol"},{"key":"3925_CR57","unstructured":"Murphy T, Hunt RH, Fried M, Krabshuis JH. World gastroenterology organization practice guidelines: diverticular disease; 2007:1\u201316; Available from: http:\/\/www.worldgastroenterology.org\/assets\/downloads\/en\/pdf\/guidelines\/07_diverticular_disease.pdf ."},{"key":"3925_CR58","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000089778","volume":"73","author":"GR Corazza","year":"2006","unstructured":"Corazza GR, Di Stefano M, Scarpignato C. Treatment of functional bowel disorders: Is there room for antibiotics? Digestion. 2006;73:38\u201346.","journal-title":"Digestion"},{"key":"3925_CR59","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3748\/wjg.v13.i2.264","volume":"13","author":"A Colecchia","year":"2007","unstructured":"Colecchia A, Vestito A, Pasqui F, et al. Efficacy of long term cyclic administration of the poorly absorbed antibiotic rifaximin in symptomatic, uncomplicated colonic diverticular disease. World J Gastroenterol. 2007;13:264\u2013269.","journal-title":"World J Gastroenterol"},{"key":"3925_CR60","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/nmo.12526","volume":"27","author":"RC Spiller","year":"2015","unstructured":"Spiller RC. Changing views on diverticular disease: impact of aging, obesity, diet, and microbiota. Neurogastroenterol Motil. 2015;27:305\u2013312.","journal-title":"Neurogastroenterol Motil"},{"key":"3925_CR61","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000089776","volume":"73","author":"C Scarpignato","year":"2006","unstructured":"Scarpignato C, Pelosini I. Experimental and clinical pharmacology of rifaximin, a gastrointestinal selective antibiotic. Digestion. 2006;73:13\u201327.","journal-title":"Digestion"},{"key":"3925_CR62","first-page":"452","volume":"24","author":"C Papi","year":"1992","unstructured":"Papi C, Ciaco A, Koch M, Capurso L. Efficacy of rifaximin on symptoms of uncomplicated diverticular disease of the colon. A pilot multicentre open trial. Diverticular Disease Study Group. Ital J Gastroenterol. 1992;24:452\u2013456.","journal-title":"Ital J Gastroenterol"},{"key":"3925_CR63","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1159\/000367625","volume":"90","author":"W Kruis","year":"2014","unstructured":"Kruis W, Germer C-T, Leifeld L. Diverticular disease: guidelines of the german society for gastroenterology, digestive and metabolic diseases and the german society for general and visceral surgery. Digestion. 2014;90:190\u2013207.","journal-title":"Digestion"},{"key":"3925_CR64","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00384-002-0396-5","volume":"18","author":"G Latella","year":"2003","unstructured":"Latella G, Pimpo MT, Sottili S, et al. Rifaximin improves symptoms of acquired uncomplicated diverticular disease of the colon. Int J Colorectal Dis. 2003;18:55\u201362.","journal-title":"Int J Colorectal Dis"},{"key":"3925_CR65","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1365-2036.1995.tb00348.x","volume":"9","author":"C Papi","year":"1995","unstructured":"Papi C, Ciaco A, Koch M, Capurso L. Efficacy of rifaximin in the treatment of symptomatic diverticular disease of the colon. A multicentre double-blind placebo-controlled trial. Aliment Pharmacol Ther. 1995;9:33\u201339.","journal-title":"Aliment Pharmacol Ther"},{"key":"3925_CR66","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/j.1365-2036.2007.03266.x","volume":"25","author":"R D\u2019Inc\u00e0","year":"2007","unstructured":"D\u2019Inc\u00e0 R, Pomerri F, Vettorato MG, et al. Interaction between rifaximin and dietary fibre in patients with diverticular disease. Aliment Pharmacol Ther. 2007;25:771\u2013779.","journal-title":"Aliment Pharmacol Ther"},{"key":"3925_CR67","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1586\/egh.09.63","volume":"3","author":"G Latella","year":"2009","unstructured":"Latella G, Scarpignato C. Rifaximin in the management of colonic diverticular disease. Expert Rev Gastroenterol Hepatol. 2009;3:585\u2013598.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"3925_CR68","first-page":"A-399","volume":"134","author":"KS Kasturi","year":"2008","unstructured":"Kasturi KS, Mummadi RR, Jaganmohan S. M1695 cyclical rifaximin for symptomatic, uncomplicated diverticular disease: a meta-analysis. Gastroenterology. 2008;134:A-399.","journal-title":"Gastroenterology"},{"key":"3925_CR69","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00508-013-0447-7","volume":"126","author":"S Stallinger","year":"2014","unstructured":"Stallinger S, Eller N, H\u00f6genauer C. Non-interventional study evaluating efficacy and tolerability of rifaximin for treatment of uncomplicated diverticular disease. Wien Klin Wochenschr. 2014;126:9\u201314.","journal-title":"Wien Klin Wochenschr"},{"key":"3925_CR70","first-page":"295","volume":"19","author":"A Zullo","year":"2010","unstructured":"Zullo A, Hassan C, Maconi G, et al. Cyclic antibiotic therapy for diverticular disease: a critical reappraisal. J Gastrointestin Liver Dis. 2010;19:295\u2013302.","journal-title":"J Gastrointestin Liver Dis"},{"key":"3925_CR71","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1097\/DCR.0b013e318223cb2b","volume":"54","author":"G Maconi","year":"2011","unstructured":"Maconi G, Barbara G, Bosetti C, Cuomo R, Annibale B. Treatment of diverticular disease of the colon and prevention of acute diverticulitis: a systematic review. Dis Colon Rectum. 2011;54:1326\u20131338.","journal-title":"Dis Colon Rectum"},{"key":"3925_CR72","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.dld.2012.09.006","volume":"45","author":"A Lanas","year":"2013","unstructured":"Lanas A, Ponce J, Bignamini A, Mearin F. One year intermittent rifaximin plus fibre supplementation vs. fibre supplementation alone to prevent diverticulitis recurrence: a proof-of-concept study. Dig Liver Dis. 2013;45:104\u2013109.","journal-title":"Dig Liver Dis"},{"key":"3925_CR73","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1111\/j.1572-0241.2000.03342.x","volume":"95","author":"RP MacDermott","year":"2000","unstructured":"MacDermott RP. Progress in understanding the mechanisms of action of 5-aminosalicylic acid. Am J Gastroenterol. 2000;95:3343\u20133345.","journal-title":"Am J Gastroenterol"},{"key":"3925_CR74","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/apt.12463","volume":"38","author":"A Tursi","year":"2013","unstructured":"Tursi A, Brandimarte G, Elisei W, et al. Randomised clinical trial: mesalazine and\/or probiotics in maintaining remission of symptomatic uncomplicated diverticular disease\u2014a double-blind, randomised, placebo-controlled study. Aliment Pharmacol Ther. 2013;38:741\u2013751.","journal-title":"Aliment Pharmacol Ther"},{"key":"3925_CR75","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1007\/s10620-011-1731-x","volume":"56","author":"A Tursi","year":"2011","unstructured":"Tursi A, Joseph RE, Streck P. Expanding applications: the potential usage of 5-aminosalicylic acid in diverticular disease. Dig Dis Sci. 2011;56:3112\u20133121.","journal-title":"Dig Dis Sci"},{"key":"3925_CR76","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1111\/apt.12248","volume":"37","author":"W Kruis","year":"2013","unstructured":"Kruis W, Meier E, Schumacher M, Mickisch O, Greinwald R, Mueller R. Randomised clinical trial: mesalazine (Salofalk granules) for uncomplicated diverticular disease of the colon\u2014a placebo-controlled study. Aliment Pharmacol Ther. 2013;37:680\u2013690.","journal-title":"Aliment Pharmacol Ther"},{"key":"3925_CR77","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1007\/s10620-007-9766-8","volume":"52","author":"G Comparato","year":"2007","unstructured":"Comparato G, Fanigliulo L, Cavallaro LG, et al. Prevention of complications and symptomatic recurrences in diverticular disease with mesalazine: a 12-month follow-up. Dig Dis Sci. 2007;52:2934\u20132941.","journal-title":"Dig Dis Sci"},{"key":"3925_CR78","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/MCG.0b013e3181a15864","volume":"44","author":"L Gatta","year":"2010","unstructured":"Gatta L, Vakil N, Vaira D, et al. Efficacy of 5-ASA in the treatment of colonic diverticular disease. J Clin Gastroenterol. 2010;44:113\u2013119.","journal-title":"J Clin Gastroenterol"},{"key":"3925_CR79","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/MCG.0b013e31828003f6","volume":"47","author":"N Stollman","year":"2013","unstructured":"Stollman N, Magowan S, Shanahan F, Quigley EMM. A randomized controlled study of mesalamine after acute diverticulitis: results of the DIVA trial. J Clin Gastroenterol. 2013;47:621\u2013629.","journal-title":"J Clin Gastroenterol"},{"key":"3925_CR80","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1007\/s00384-013-1722-9","volume":"28","author":"F Parente","year":"2013","unstructured":"Parente F, Bargiggia S, Prada A, et al. Intermittent treatment with mesalazine in the prevention of diverticulitis recurrence: a randomised multicentre pilot double-blind placebo-controlled study of 24-month duration. Int J Colorectal Dis. 2013;28:1423\u20131431.","journal-title":"Int J Colorectal Dis"},{"key":"3925_CR81","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1053\/j.gastro.2014.07.004","volume":"147","author":"JB Raskin","year":"2014","unstructured":"Raskin JB, Kamm MA, Jamal MM, et al. Mesalamine did not prevent recurrent diverticulitis in phase 3 controlled trials. Gastroenterology. 2014;147:793\u2013802.","journal-title":"Gastroenterology"},{"key":"3925_CR82","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1159\/000342079","volume":"61","author":"M Bermudez-Brito","year":"2012","unstructured":"Bermudez-Brito M, Plaza-D\u00edaz J, Mu\u00f1oz-Quezada S, G\u00f3mez-Llorente C, Gil A. Probiotic mechanisms of action. Ann Nutr Metab. 2012;61:160\u2013174.","journal-title":"Ann Nutr Metab"},{"key":"3925_CR83","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1111\/j.1440-1746.2010.06444.x","volume":"25","author":"N Narula","year":"2010","unstructured":"Narula N, Marshall JK. Role of probiotics in management of diverticular disease. J Gastroenterol Hepatol. 2010;25:1827\u20131830.","journal-title":"J Gastroenterol Hepatol"},{"key":"3925_CR84","first-page":"29","volume":"15","author":"S Giaccari","year":"1993","unstructured":"Giaccari S, Tronci S, Falconieri M, Ferrieri A. Long-term treatment with rifaximin and lactobacilli in post-diverticulitic stenoses of the colon. Riv Eur Sci Med Farmacol. 1993;15:29\u201334.","journal-title":"Riv Eur Sci Med Farmacol"},{"key":"3925_CR85","first-page":"13","volume":"57","author":"B Annibale","year":"2011","unstructured":"Annibale B, Maconi G, Lahner E, De Giorgi F, Cuomo R. Efficacy of Lactobacillus paracasei sub. paracasei F19 on abdominal symptoms in patients with symptomatic uncomplicated diverticular disease: a pilot study. Minerva Gastroenterol Dietol. 2011;57:13\u201322.","journal-title":"Minerva Gastroenterol Dietol"},{"key":"3925_CR86","first-page":"31","volume":"19","author":"P Lamiki","year":"2010","unstructured":"Lamiki P, Tsuchiya J, Pathak S, et al. Probiotics in diverticular disease of the colon: an open label study. J Gastrointestin Liver Dis. 2010;19:31\u201336.","journal-title":"J Gastrointestin Liver Dis"},{"key":"3925_CR87","doi-asserted-by":"crossref","first-page":"5918","DOI":"10.3748\/wjg.v18.i41.5918","volume":"18","author":"E Lahner","year":"2012","unstructured":"Lahner E, Esposito G, Zullo A, et al. High-fibre diet and Lactobacillus paracasei B21060 in symptomatic uncomplicated diverticular disease. World J Gastroenterol. 2012;18:5918\u20135924.","journal-title":"World J Gastroenterol"},{"key":"3925_CR88","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/00042737-200303000-00015","volume":"15","author":"P Fric","year":"2003","unstructured":"Fric P, Zavoral M. The effect of non-pathogenic Escherichia coli in symptomatic uncomplicated diverticular disease of the colon. Eur J Gastroenterol Hepatol. 2003;15:313\u2013315.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"3925_CR89","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s00384-007-0299-6","volume":"22","author":"A Tursi","year":"2007","unstructured":"Tursi A, Brandimarte G, Giorgetti GM, Elisei W, Aiello F. Balsalazide and\/or high-potency probiotic mixture (VSL#3) in maintaining remission after attack of acute, uncomplicated diverticulitis of the colon. Int J Colorectal Dis. 2007;22:1103\u20131108.","journal-title":"Int J Colorectal Dis"},{"key":"3925_CR90","first-page":"149","volume":"50","author":"L Dughera","year":"2004","unstructured":"Dughera L, Serra AM, Battaglia E, Tibaudi D, Navino M, Emanuelli G. Acute recurrent diverticulitis is prevented by oral administration of a polybacterial lysate suspension. Minerva Gastroenterol Dietol. 2004;50:149\u2013153.","journal-title":"Minerva Gastroenterol Dietol"},{"key":"3925_CR91","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1136\/bmj.282.6273.1353","volume":"282","author":"MH Ornstein","year":"1981","unstructured":"Ornstein MH, Littlewood ER, Baird IM, Fowler J, North WR, Cox AG. Are fibre supplements really necessary in diverticular disease of the colon? A controlled clinical trial. Br Med J (Clin Res Ed). 1981;282:1353\u20131356.","journal-title":"Br Med J (Clin Res Ed)"},{"key":"3925_CR92","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1742-1241.1990.tb10835.x","volume":"44","author":"BJ Smits","year":"1990","unstructured":"Smits BJ, Whitehead AM, Prescott P. Lactulose in the treatment of symptomatic diverticular disease: a comparative study with high-fibre diet. Br J Clin Pract. 1990;44:314\u2013318.","journal-title":"Br J Clin Pract"},{"key":"3925_CR93","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s10620-005-2478-z","volume":"50","author":"F Mario Di","year":"2005","unstructured":"Di Mario F, Aragona G, Leandro G, et al. Efficacy of mesalazine in the treatment of symptomatic diverticular disease. Dig Dis Sci. 2005;50:581\u2013586.","journal-title":"Dig Dis Sci"},{"key":"3925_CR94","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1159\/000103896","volume":"25","author":"G Comparato","year":"2007","unstructured":"Comparato G, Fanigliulo L, Aragona G, et al. Quality of life in uncomplicated symptomatic diverticular disease: Is it another good reason for treatment? Dig Dis. 2007;25:252\u2013259.","journal-title":"Dig Dis"},{"key":"3925_CR95","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/S1590-8658(02)80110-4","volume":"34","author":"A Tursi","year":"2002","unstructured":"Tursi A, Brandimarte G, Daffin\u00e0 R. Long-term treatment with mesalazine and rifaximin versus rifaximin alone for patients with recurrent attacks of acute diverticulitis of colon. Dig Liver Dis. 2002;34:510\u2013515.","journal-title":"Dig Liver Dis"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-015-3925-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-015-3925-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-015-3925-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T18:37:26Z","timestamp":1718131046000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-015-3925-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,12]]},"references-count":95,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["3925"],"URL":"https:\/\/doi.org\/10.1007\/s10620-015-3925-0","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,12]]}}}